Boost Run Analyst Price Targets

Wall Street analyst price targets and consensus rating for Boost Run (BRUN).

Price Target Range — 3 Quarters

Analyst Consensus — 4 Analysts

4Buy

Consensus RatingBuy# Analysts4Avg. Consensus PT$37Upside to Avg. PT+186.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 18, 2026	Northland Capital Markets	Nehal Chokshi	Initiate	Outperform	$36
Aug 14, 2026	BTIG	Gregory Lewis	Maintained	Buy	$45
Jun 25, 2026	BTIG	Gregory Lewis	Initiate	Buy	$45
Jun 23, 2026	Craig-Hallum	George Sutton	Maintained	Buy	$45
Jun 4, 2026	Craig-Hallum	George Sutton	PT Raise	Buy	$30→$45
Jun 4, 2026	DA Davidson	Gil Luria	Maintained	Buy	$45
Jun 1, 2026	DA Davidson	Gil Luria	PT Raise	Buy	$25→$45
May 13, 2026	DA Davidson	Gil Luria	PT Raise	Buy	$20→$25
May 12, 2026	Craig-Hallum	George Sutton	Initiate	Buy	$30
Oct 7, 2025	DA Davidson	—	Initiate	Buy	$15

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Northland Capital Markets Initiates Coverage On Boost Run with Outperform Rating, Announces Price Target of $36

Northland Capital Markets analyst Nehal Chokshi initiates coverage on Boost Run (NASDAQ:BRUN) with a Outperform rating and announces Price Target of $36.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on Boost Run, Maintains $45 Price Target

BTIG analyst Gregory Lewis reiterates Boost Run (NASDAQ:BRUN) with a Buy and maintains $45 price target.

Benzinga Newsdesk

This Keurig Dr Pepper Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday

Top Wall Street analysts changed outlook on top names. See all changes incl. upgrades, downgrades & initiations on analyst ratings page.

Avi Kapoor

This PVH Analyst Turns Bearish; Here Are Top 3 Downgrades For Thursday

Wall Street analysts change outlook on top names, with downgrades and initiations. See analyst ratings page for complete view.

Avi Kapoor

This Tonix Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Analysts changed outlook on top names, including Intel and Arrow Financial. See ratings page. TNXP stock may be worth considering, analysts say.

Avi Kapoor

PRO
BTIG Initiates Coverage On Boost Run with Buy Rating, Announces Price Target of $45

BTIG analyst Gregory Lewis initiates coverage on Boost Run (NASDAQ:BRUN) with a Buy rating and announces Price Target of $45.

Benzinga Newsdesk

Boost Run Inc

Boost Run Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Northland Capital Markets Initiates Coverage On Boost Run with Outperform Rating, Announces Price Target of $36

PRO
BTIG Reiterates Buy on Boost Run, Maintains $45 Price Target

This Keurig Dr Pepper Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday

This PVH Analyst Turns Bearish; Here Are Top 3 Downgrades For Thursday

This Tonix Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

PRO
BTIG Initiates Coverage On Boost Run with Buy Rating, Announces Price Target of $45

People Also Watch

People Also Watch

Boost Run Inc

Boost Run Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRONorthland Capital Markets Initiates Coverage On Boost Run with Outperform Rating, Announces Price Target of $36

PROBTIG Reiterates Buy on Boost Run, Maintains $45 Price Target

This Keurig Dr Pepper Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday

This PVH Analyst Turns Bearish; Here Are Top 3 Downgrades For Thursday

This Tonix Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

PROBTIG Initiates Coverage On Boost Run with Buy Rating, Announces Price Target of $45

People Also Watch

People Also Watch

PRO
Northland Capital Markets Initiates Coverage On Boost Run with Outperform Rating, Announces Price Target of $36

PRO
BTIG Reiterates Buy on Boost Run, Maintains $45 Price Target

PRO
BTIG Initiates Coverage On Boost Run with Buy Rating, Announces Price Target of $45